&host=rt.com&uri=/business/news/veropharm-posts-fy-2008-net-profit-of-369-million/&via=(none)&ua=CCBot/1.0 (+http://www.commoncrawl.org/bot.html))
Veropharm posts FY 2008 Net Profit of $36.9 million
Published: 22 April, 2009, 11:50
TAGS: Retail, Corporate Results, Economy, Finance
Russian drugmaker, Veropharm, has posted a FY 2008 Net Profit of $36.9 million under IFRS.
The bottom line is up 33% on the FY 2007 result with EBITDA up 24% to $52.5 million on the back of a 24% rise in sales to $172.9 million.
The company noted the increase in sales of prescription drugs to 66% of total sales, with sales of Bilumid increasing by 102%, Taytax by 97%, and Cerepro up 114%. Sales of Over the Counter drugs remained unchanged at 8% of sales.
Veropharm also noted a rise in debt to $24.5 million as at the end of December 2008, although adding that this did not exceed 20% of Net assets.
22.04.2009, 10:40
Cargo volumes plummet as crisis hits homeRussian Railways says April is shaping up to be a record bad month for cargo traffic, with air and rail cargo volumes down. |
22.04.2009, 16:39
Megafon posts FY 2008 Net Profit of 44.3 billion RoublesRussian mobile operator Megafon has posted a FY 2008 Net Profit of 44.3 billion Roubles ($1.4 billion) under U.S. GAAP. |
